Results 51 to 60 of about 22,517 (214)

Elevated miR-16-5p induces somatostatin receptor 2 expression in neuroendocrine tumor cells.

open access: yesPLoS ONE, 2020
Somatostatin analogs, which are used to treat neuroendocrine tumors, inhibit hormone secretion or promote tumor shrinkage; however, their efficacy varies between patients, possibly because of differential expression of somatostatin receptors (SSTRs) in ...
HanHee Jo   +8 more
doaj   +1 more source

Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.

open access: yesJournal of Endocrinology, 2016
Somatostatin analogs (SSA) are the mainstay of pharmacological treatment for pituitary adenomas. However, some patients escape from therapy with octreotide, a somatostatin receptor 2 (sst2)-preferring SSA, and pasireotide, a novel multi-sst-preferring ...
A. Ibáñez-Costa   +17 more
semanticscholar   +1 more source

The use of octreotide in pediatric patients: Practical applications for gastrointestinal disorders and beyond: A narrative review

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Somatostatin is a naturally occurring polypeptide hormone that exerts its effect on the gastrointestinal tract by reducing exocrine and endocrine secretion, resulting in decreased motility, gastric emptying, splanchnic blood flow, fat absorption, lymphatic flow, and gallbladder contraction.
Bailey Dunn   +4 more
wiley   +1 more source

Role of octreotide and instillation of povidone-iodine in the treatment of lymphorrhea in renal transplantation: A comparative study

open access: yesIndian Journal of Transplantation
Background: Lymphorrhea is a minor complication after kidney transplantation but may develop into a lymphocele and prolong hospital stay. Treatment is conservative based on percutaneous drainage until lymphatic leakage cessation.
Vaibhav Kant Baderiya   +2 more
doaj   +1 more source

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

open access: yesBMC Endocrine Disorders, 2016
BackgroundMany patients with acromegaly do not achieve biochemical control with first-generation somatostatin analogues. A large, multicenter, randomized, Phase III core study demonstrated that pasireotide LAR had significantly superior efficacy over ...
M. Bronstein   +12 more
semanticscholar   +1 more source

Octreotide Attenuates Acute Kidney Injury after Hepatic Ischemia and Reperfusion by Enhancing Autophagy

open access: yesScientific Reports, 2017
Octreotide exerts a protective effect in hepatic ischemia-reperfusion (HIR) injury. However, whether octreotide preconditioning could also reduce acute kidney injury (AKI) after HIR is unknown.
Huiping Sun   +8 more
semanticscholar   +1 more source

Octreotide and chylothorax

open access: yesCurrent Opinion in Pulmonary Medicine, 2006
This article reviews the current literature concerning the role of somatostatin and its synthetic analogue, octreotide, in the treatment of chylothorax.Management of chylothorax includes evacuation of the pleural cavity through a chest tube to alleviate dyspnoea, and dietary fat restriction aimed at reducing lymph flow.
openaire   +4 more sources

Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?

open access: yesActa Ophthalmologica, EarlyView.
Abstract Gyrate atrophy of the choroid and retina (GACR; OMIM #258870) is a rare early‐onset autosomal recessive disorder, caused by bi‐allelic pathogenic variants in the gene coding for ornithine aminotransferase (OAT) resulting in hyperornithinaemia.
Mark J. N. Buijs   +12 more
wiley   +1 more source

Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2015
BACKGROUND A novel oral octreotide formulation was tested for efficacy and safety in a phase III, multicenter, open-label, dose-titration, baseline-controlled study in patients with acromegaly.
S. Melmed   +24 more
semanticscholar   +1 more source

Serial correlation between saliva and blood beta‐hydroxybutyrate levels in children commencing the ketogenic diet for epilepsy

open access: yesEpilepsia, EarlyView.
Abstract Objectives Accurate and user‐friendly methods to measure beta‐hydroxybutyrate (BHB) concentration are needed to guide the optimal use of ketogenic diet therapy (KDT). We aimed to determine the correlation between serum, capillary, and salivary BHB concentration, and to validate an electrochemical salivary BHB point‐of‐care test (POCT) in ...
Neha Kaul   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy